{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T21:47:13Z","timestamp":1774388833951,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s42000-025-00694-8","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T03:51:08Z","timestamp":1751946668000},"page":"261-266","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rare metastatic sites in three patients with RAI-refractory differentiated thyroid cancer (DTC)"],"prefix":"10.1007","volume":"25","author":[{"given":"Olga","family":"Karapanou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7313-8391","authenticated-orcid":false,"given":"Grigoris","family":"Effraimidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Effie","family":"Petinellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Michalaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miltiadis","family":"Krokidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1421-0653","authenticated-orcid":false,"given":"Katerina","family":"Saltiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"694_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1159\/000502229","volume":"8","author":"L Fugazzola","year":"2019","unstructured":"Fugazzola L, Elisei R, Fuhrer D, Jarzab B, Leboulleux S, Newbold K, Smit J (2019) 2019 European thyroid association guidelines for the treatment and Follow-Up of advanced Radioiodine-Refractory thyroid Cancer. Eur \u03a4hyroid J 8:227\u2013245. https:\/\/doi.org\/10.1159\/000502229","journal-title":"Eur \u03a4hyroid J"},{"key":"694_CR2","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1210\/jc.2005-2838","volume":"91","author":"C Durante","year":"2006","unstructured":"Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP, Caillou B, Ricard M, Lumbroso JD, De Vathaire F et al (2006) Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 91:2892\u20132899. https:\/\/doi.org\/10.1210\/jc.2005-2838","journal-title":"J Clin Endocrinol Metab"},{"key":"694_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s40618-020-01374-7","volume":"44","author":"A Nervo","year":"2021","unstructured":"Nervo A, Ragni A, Retta F, Gallo M, Piovesan A, Liberini V, Gatti M, Ricardi U, Deandreis D, Arvat E (2021) Bone metastases from differentiated thyroid carcinoma: current knowledge and open issues. J Endocrinol Invest 44:403\u2013419. https:\/\/doi.org\/10.1007\/s40618-020-01374-7","journal-title":"J Endocrinol Invest"},{"key":"694_CR4","doi-asserted-by":"publisher","first-page":"5281452","DOI":"10.1155\/2018\/5281452","volume":"2018","author":"MJH Rahal","year":"2018","unstructured":"Rahal MJH, Karam KM, Nasser SM, Daher JA, Abdel Nour HG, Nehme AH, Moucharafieh RC (2018) Calcaneus metastasis from follicular thyroid carcinoma 12 years after total thyroidectomy. Case Rep Orthop 2018:5281452. https:\/\/doi.org\/10.1155\/2018\/5281452","journal-title":"Case Rep Orthop"},{"key":"694_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1530\/EDM-23-0103","volume":"2023","author":"O Elshafie","year":"2023","unstructured":"Elshafie O, Jain A, Bichpuria S, Rassou Y, Hashmi SF, Bou Khalil A (2023) Calcaneus metastasis: a rare presentation of poorly differentiated thyroid cancer. Endocrinol Diabetes Metab Case Rep 2023:23\u20130103. https:\/\/doi.org\/10.1530\/EDM-23-0103","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"694_CR6","first-page":"72","volume":"14","author":"C Borde","year":"2011","unstructured":"Borde C, Basu S, Kand P, Arya S, Shet T (2011) Bilateral renal metastases from papillary thyroid carcinoma on post 131I treatment scan: flip-flop sign, radioiodine SPET, 18F-FDG PET, CECT and histopathological correlation. Hell J Nucl Med 14:72\u201373","journal-title":"Hell J Nucl Med"},{"key":"694_CR7","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s13139-016-0462-5","volume":"51","author":"A Claimon","year":"2017","unstructured":"Claimon A, Suh M, Cheon GJ, Lee DS, Kim EE, Chung JK (2017) Bilateral renal metastasis of H\u00fcrthle cell thyroid Cancer with discordant uptake between I-131 sodium iodide and F-18 FDG. Nucl Med Mol Imaging 51:256\u2013260. https:\/\/doi.org\/10.1007\/s13139-016-0462-5","journal-title":"Nucl Med Mol Imaging"},{"key":"694_CR8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.12659\/AJCR.894935","volume":"16","author":"SS Lubana","year":"2015","unstructured":"Lubana SS, Singh N, Tuli SS, Bashir T, Sachmechi I, Kemeny MM (2015) Follicular variant of papillary thyroid Cancer with bilateral renal metastases discovered incidentally during Work-Up of primary endometrial cancer: A rare occurrence. Am J Case Rep 16:459\u2013468. https:\/\/doi.org\/10.12659\/AJCR.894935","journal-title":"Am J Case Rep"},{"key":"694_CR9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1177\/10668969221138860","volume":"31","author":"B Youssef","year":"2023","unstructured":"Youssef B, Hanna K, Bowman A, Ardor GD, Alhaj AM, Nassar A (2023) Metastatic thyroid carcinoma to the kidneys presenting initially as bilateral renal masses: A rare case report and literature review. Int J Surg Pathol 31:795\u2013800. https:\/\/doi.org\/10.1177\/10668969221138860","journal-title":"Int J Surg Pathol"},{"key":"694_CR10","doi-asserted-by":"publisher","first-page":"7083","DOI":"10.3892\/ol.2018.8216","volume":"15","author":"L Herbowski","year":"2018","unstructured":"Herbowski L (2018) Skeletal muscle metastases from papillary and follicular thyroid carcinomas: an extensive review of the literature. Oncol Lett 15:7083\u20137089. https:\/\/doi.org\/10.3892\/ol.2018.8216","journal-title":"Oncol Lett"},{"key":"694_CR11","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1056\/NEJMoa1406470","volume":"372","author":"M Schlumberger","year":"2015","unstructured":"Schlumberger M, Tahara M, Wirth LJ (2015) Lenvatinib in radioiodine-refractory thyroid cancer. N Engl J Med 372:1868. https:\/\/doi.org\/10.1056\/NEJMoa1406470","journal-title":"N Engl J Med"},{"key":"694_CR12","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.7150\/thno.57689","volume":"11","author":"JM Oh","year":"2021","unstructured":"Oh JM, Ahn BC (2021) Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS. Theranostics 11:6251\u20136277. https:\/\/doi.org\/10.7150\/thno.57689","journal-title":"Theranostics"},{"key":"694_CR13","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMc1613118","volume":"375","author":"JA Fagin","year":"2016","unstructured":"Fagin JA, Wells SA Jr (2016) Biologic and clinical perspectives on thyroid Cancer. N Engl J Med 375:2307. https:\/\/doi.org\/10.1056\/NEJMc1613118","journal-title":"N Engl J Med"},{"key":"694_CR14","doi-asserted-by":"publisher","first-page":"R141","DOI":"10.1530\/JME-17-0134","volume":"59","author":"MH Tesselaar","year":"2017","unstructured":"Tesselaar MH, Smit JW, Nagarajah J, Netea-Maier RT, Plantinga TS (2017) Pathological processes and therapeutic advances in Radioiodide refractory thyroid cancer. J Mol Endocrinol 59:R141\u2013r154. https:\/\/doi.org\/10.1530\/JME-17-0134","journal-title":"J Mol Endocrinol"},{"key":"694_CR15","doi-asserted-by":"publisher","first-page":"592202","DOI":"10.3389\/fonc.2020.592202","volume":"10","author":"A Porter","year":"2020","unstructured":"Porter A, Wong DJ (2020) Perspectives on the treatment of advanced thyroid cancer: approved therapies, resistance mechanisms, and future directions. Front Oncol 10:592202. https:\/\/doi.org\/10.3389\/fonc.2020.592202","journal-title":"Front Oncol"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-025-00694-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-025-00694-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-025-00694-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T19:28:50Z","timestamp":1774380530000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-025-00694-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["694"],"URL":"https:\/\/doi.org\/10.1007\/s42000-025-00694-8","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"1 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Signed informed consent could not be obtained from the patient or a proxy but has been approved by the treating institution.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed patient consent for publication"}},{"value":"The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the work reported.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"None to declare","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}